Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | August 05, 2026 | August 14, 2026 |
| Bausch Health Companies Inc.BHC · Entity 4363 | Director · Chief Executive Officer | February 27, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date August 05, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 27,583 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 27,583 |
Bausch Health Companies Inc.
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 2,315,374 |
Ending reported balance
After 2026-03-02 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-02-27 · Tax withholding · Disposed 83,093 · Balance 3,536,941 F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Row 2 · 2026-03-02 · Tax withholding · Disposed 83,705 · Balance 3,453,236 F2: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Row 3 · 2026-03-02 · Other · Disposed 1,137,862 · Balance 2,315,374 F3: Reflects the settlement in cash of 1,137,862 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The settlement in cash is exempt under Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F2: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F3: Reflects the settlement in cash of 1,137,862 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The settlement in cash is exempt under Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 3, 2026 22:41 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | OtherCommon Shares, No Par Value | 1,137,862 | $5.95 | $6,770,278.90 |
DisclosureSEC source: 0000885590-26-000037 · form4.xml · nonDerivative · entry 3 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,315,374 F3 · shares: Reflects the settlement in cash of 1,137,862 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The settlement in cash is exempt under Rule 16b-3(e). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 22:41 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 83,705 | $5.95 | $498,044.75 |
DisclosureSEC source: 0000885590-26-000037 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,453,236 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 22:41 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 83,093 | $5.93 | $492,741.49 |
DisclosureSEC source: 0000885590-26-000037 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,536,941 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 22:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 116,502 | $6.04 | $703,672.08 |
DisclosureSEC source: 0000885590-26-000025 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,620,034 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 22:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 815,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000025 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,736,536 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 23:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,137,862 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000013 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,921,111 F1 · shares: Reflects performance-based restricted share units ("PSUs"), originally granted to the Reporting Person on March 2, 2023, which were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee of the Board of Directors of the Issuer of the level of achievement of the financial performance metrics applicable to the PSUs for the performance period from January 1, 2023 through December 31, 2025. The PSUs remain subject to a service-based vesting condition through March 2, 2026. Subject to the satisfaction by the Reporting Person of the service-based vesting condition, the Issuer will deliver to the Reporting Person the number of Common Shares earned based on achievement of the financial performance metrics as soon as administratively practicable thereafter. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:07 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 96,911 | $7.44 | $721,017.84 |
DisclosureSEC source: 0001127602-25-007482 · form4.xml · nonDerivative · entry 3 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,783,249 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:07 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 85,100 | $7.44 | $633,144.00 |
DisclosureSEC source: 0001127602-25-007482 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,880,160 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:07 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 24,838 | $7.44 | $184,794.72 |
DisclosureSEC source: 0001127602-25-007482 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,965,260 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:39 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 635,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007283 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,990,098 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| August 30, 2024 Filed Sep 3, 2024 20:21 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 14,683 | $5.93 | $87,070.19 |
DisclosureSEC source: 0001127602-24-023306 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,354,673 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 87,803 | $9.89 | $868,371.67 |
DisclosureSEC source: 0001127602-24-008124 · form4.xml · nonDerivative · entry 5 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,369,356 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 23,871 | $9.89 | $236,084.19 |
DisclosureSEC source: 0001127602-24-008124 · form4.xml · nonDerivative · entry 4 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,457,159 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,413 | $9.89 | $23,864.57 |
DisclosureSEC source: 0001127602-24-008124 · form4.xml · nonDerivative · entry 3 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,481,030 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,895 | $9.89 | $28,631.55 |
DisclosureSEC source: 0001127602-24-008124 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,483,443 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 519,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-008124 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,486,338 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-half on each of the first two anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares"). Read SEC document |
| February 29, 2024 Filed Jun 5, 2024 20:45 UTC Amendment | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 519,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017939 · form4a.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,486,338 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 21:09 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 14,111 | $8.46 | $119,379.06 |
DisclosureSEC source: 0001127602-23-023714 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 967,010 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,357 | $9.16 | $21,590.12 |
DisclosureSEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 6 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 981,121 F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of performance-based Restricted Share Units. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 4,348 | $9.16 | $39,827.68 |
DisclosureSEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 5 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983,478 F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of performance-based Restricted Share Units. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,577 | $9.16 | $14,445.32 |
DisclosureSEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 4 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 987,826 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,893 | $9.16 | $17,339.88 |
DisclosureSEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 3 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989,403 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 523,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 991,296 F2 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 17,432 | $9.25 | $161,246.00 |
DisclosureSEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,141 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,069 | $9.57 | $19,800.33 |
DisclosureSEC source: 0001127602-23-007985 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,573 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 4,258 | $9.57 | $40,749.06 |
DisclosureSEC source: 0001127602-23-007985 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,642 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 20:35 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Disposition to issuerCommon Shares, No Par Value | 15,389 | $6.59 | $101,413.51 |
DisclosureSEC source: 0001127602-22-022017 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,900 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:44 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 19,575 | $9.40 | $184,005.00 |
DisclosureSEC source: 0000899243-22-017871 · doc4.xml · derivative · entry 6 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 0 shares Expires 2022-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F2 · shares: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. F2 · derivative.exercise_date: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:44 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantRestricted Share Units · Derivative | 19,575 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-017871 · doc4.xml · derivative · entry 5 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 19,575 shares Expires 2022-05-10 F3 · derivative.exercise_price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F2 · shares: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. F3 · price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F2 · derivative.exercise_date: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:44 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 12,447 | $9.40 | $117,001.80 |
DisclosureSEC source: 0000899243-22-017871 · doc4.xml · derivative · entry 4 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 0 shares Expires 2022-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F1 · shares: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. F1 · derivative.exercise_date: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:44 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantRestricted Share Units · Derivative | 12,447 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-017871 · doc4.xml · derivative · entry 3 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 12,447 shares Expires 2022-05-10 F3 · derivative.exercise_price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F1 · shares: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. F3 · price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. F1 · derivative.exercise_date: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:44 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 19,575 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-017871 · doc4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. F3 · price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:44 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 12,447 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-017871 · doc4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. F3 · price: Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 5,564 | $23.61 | $131,366.04 |
DisclosureSEC source: 0001127602-22-008483 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,267 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:50 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 565,330 | $0.00 Strike: $24.17 | $0.00 |
DisclosureSEC source: 0001127602-22-008296 · form4.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,330 Underlying: Common Shares, No Par Value · 565,330 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:50 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 152,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008296 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,831 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 24,292 | $24.35 Strike: $24.35 | $591,510.20 |
DisclosureSEC source: 0000899243-22-008826 · doc4.xml · derivative · entry 6 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 0 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantRestricted Share Units · Derivative | 24,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-008826 · doc4.xml · derivative · entry 5 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 24,292 shares Expires 2022-02-27 F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis F2 · price: Each PSU converts into Common Shares on a one-for-one basis F1 · derivative.exercise_date: Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,402 | $24.35 | $58,488.70 |
DisclosureSEC source: 0000899243-22-008826 · doc4.xml · nonDerivative · entry 4 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,141 F5 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 8,782 | $24.35 | $213,841.70 |
DisclosureSEC source: 0000899243-22-008826 · doc4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,735 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 24,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-008826 · doc4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. F2 · price: Each PSU converts into Common Shares on a one-for-one basis Read SEC document |
| February 26, 2022 Filed Mar 3, 2022 02:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,192 | $24.35 | $53,375.20 |
DisclosureSEC source: 0000899243-22-008826 · doc4.xml · nonDerivative · entry 3 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,543 F4 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs"). Read SEC document |
| December 15, 2021 Filed Dec 31, 2021 00:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 3,461 | $24.49 | $84,759.89 |
DisclosureSEC source: 0001127602-21-032076 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,225 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:09 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantRestricted Share Units · Derivative | 90,260 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024865 · form4.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,260 Underlying: Common Shares, No Par Value · 90,260 shares Expires not disclosed F2 · derivative.exercise_price: Represents a grant of performance-based RSUs ("PSUs"), each of which represents a contingent right to receive one Common Share. The number of Common Shares to be distributed upon the vesting of the PSUs will be determined by the Issuer's Total Shareholder Return ("TSR"), as measured for the 20 trading days preceding the TSR measurement date, and will be between 0% to 200% of the PSU target reported in Column 5. F2 · derivative.exercise_date: Represents a grant of performance-based RSUs ("PSUs"), each of which represents a contingent right to receive one Common Share. The number of Common Shares to be distributed upon the vesting of the PSUs will be determined by the Issuer's Total Shareholder Return ("TSR"), as measured for the 20 trading days preceding the TSR measurement date, and will be between 0% to 200% of the PSU target reported in Column 5. F2 · derivative.expiration_date: Represents a grant of performance-based RSUs ("PSUs"), each of which represents a contingent right to receive one Common Share. The number of Common Shares to be distributed upon the vesting of the PSUs will be determined by the Issuer's Total Shareholder Return ("TSR"), as measured for the 20 trading days preceding the TSR measurement date, and will be between 0% to 200% of the PSU target reported in Column 5. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:09 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 90,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024865 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,686 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares"). Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 17,480 | $32.97 | $576,315.60 |
DisclosureSEC source: 0001127602-21-010160 · form4.xml · nonDerivative · entry 3 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,426 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 9,161 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010160 · form4.xml · derivative · entry 4 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,161 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. F4 · derivative.exercise_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F4 · derivative.expiration_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 14,776 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 28,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010160 · form4.xml · nonDerivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,906 F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:49 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 9,161 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010160 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-qualified Stock Options (right To Purchase) · Derivative | 47,151 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009559 · form4.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,151 Underlying: Common Shares, No Par Value · 47,151 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.